New-onset diabetes after transplantation 2003 international consensus guidelines - An endocrinologist's view

被引:128
作者
Davidson, JA
Wilkinson, A
机构
[1] Endocrine & Diabet Associates Texas, Dallas, TX 75230 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA
关键词
D O I
10.2337/diacare.27.3.805
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New-onset diabetes is a major complication of transplantation that appears to have a high incidence. The condition is currently under diagnosed due to a previous lack of a standard definition; however, the recent International Consensus Guidelines for New-Onset Diabetes after Transplantation will help to establish a standard definition and assist in the diagnosis of the condition. New-onset diabetes after transplantation shares many similarities with type 2 diabetes, and recent guidelines thus recommend that its management should follow many of the therapeutic and preventative steps taken for type 2 diabetes (12) (Fig. 2). However, important therapeutic differences exist between the two conditions, and transplant recipients should not be considered comparable with patients with diabetes in the general population. It is important that endocrinologists are aware of the similarities and differences between diabetes in the transplant and general populations. Adoption of appropriate management strategies may reduce the transplant recipient's risk for developing new-onset diabetes after transplantation and thus minimize the long-term consequences associated with the condition.
引用
收藏
页码:805 / 812
页数:8
相关论文
共 57 条
[1]  
*AM ASS CLIN END, 2002, DIABETES CARE S1, V25, pS85
[2]  
*AM ASS CLIN END, 2002, ENDOCR PRACT S1, V8, P41
[3]  
*AM ASS CLIN END, 2003, DIABETES CARE S1, V26, pS83
[4]  
American Diabetes Association, 2002, DIABETES CARE S1, V25, pS71, DOI DOI 10.2337/DIACARE.25.2007.S71
[5]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[6]   SOME CHARACTERISTICS OF STEROID DIABETES - A STUDY IN RENAL-TRANSPLANT RECIPIENTS RECEIVING HIGH-DOSE CORTICOSTEROID-THERAPY [J].
ARNER, P ;
GUNNARSSON, R ;
BLOMDAHL, S ;
GROTH, CG .
DIABETES CARE, 1983, 6 (01) :23-25
[7]   Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality [J].
Baid, S ;
Cosimi, AB ;
Farrell, ML ;
Schoenfeld, DA ;
Feng, S ;
Chung, RT ;
Tolkoff-Rubin, N ;
Pascual, M .
TRANSPLANTATION, 2001, 72 (06) :1066-1072
[8]  
Benhamou PY, 2002, DIABETES METAB, V28, P166
[9]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[10]   THE IMPACT OF CYCLOSPORINE AND COMBINATION IMMUNOSUPPRESSION ON THE INCIDENCE OF POSTTRANSPLANT DIABETES IN RENAL-ALLOGRAFT RECIPIENTS [J].
BOUDREAUX, JP ;
MCHUGH, L ;
CANAFAX, DM ;
ASCHER, N ;
SUTHERLAND, DER ;
PAYNE, W ;
SIMMONS, RL ;
NAJARIAN, JS ;
FRYD, DS .
TRANSPLANTATION, 1987, 44 (03) :376-381